2/24
08:54 pm
ikt
Form 4 Inhibikase Therapeutics, For: Feb 21 Filed by: Cabell Christopher
Medium
Report
Form 4 Inhibikase Therapeutics, For: Feb 21 Filed by: Cabell Christopher
2/24
08:54 pm
ikt
Form 4 Inhibikase Therapeutics, For: Feb 21 Filed by: Aurentz Vincent
Medium
Report
Form 4 Inhibikase Therapeutics, For: Feb 21 Filed by: Aurentz Vincent
2/24
08:49 pm
ikt
Form 4 Inhibikase Therapeutics, For: Feb 21 Filed by: Munshi Amit
Medium
Report
Form 4 Inhibikase Therapeutics, For: Feb 21 Filed by: Munshi Amit
2/17
06:22 pm
ikt
Form SCHEDULE 13G/A Inhibikase Therapeutics, Filed by: ADAR1 Capital Management, LLC
Medium
Report
Form SCHEDULE 13G/A Inhibikase Therapeutics, Filed by: ADAR1 Capital Management, LLC
2/17
04:32 pm
ikt
Form SCHEDULE 13G/A Inhibikase Therapeutics, Filed by: Fairmount Funds Management LLC
Medium
Report
Form SCHEDULE 13G/A Inhibikase Therapeutics, Filed by: Fairmount Funds Management LLC
2/17
04:00 pm
ikt
Form SCHEDULE 13G/A Inhibikase Therapeutics, Filed by: PERCEPTIVE ADVISORS LLC
Medium
Report
Form SCHEDULE 13G/A Inhibikase Therapeutics, Filed by: PERCEPTIVE ADVISORS LLC
2/13
05:05 pm
ikt
Form SCHEDULE 13G/A Inhibikase Therapeutics, Filed by: Nantahala Capital Management, LLC
Low
Report
Form SCHEDULE 13G/A Inhibikase Therapeutics, Filed by: Nantahala Capital Management, LLC
2/13
11:31 am
ikt
Form SCHEDULE 13G/A Inhibikase Therapeutics, Filed by: Sands Capital Life Sciences Pulse Fund II, L.P.
Low
Report
Form SCHEDULE 13G/A Inhibikase Therapeutics, Filed by: Sands Capital Life Sciences Pulse Fund II, L.P.
1/7
04:23 pm
ikt
Form 4 Inhibikase Therapeutics, For: Jan 05 Filed by: Iwicki Mark T
High
Report
Form 4 Inhibikase Therapeutics, For: Jan 05 Filed by: Iwicki Mark T
1/7
04:22 pm
ikt
Form 4 Inhibikase Therapeutics, For: Jan 05 Filed by: Cabell Christopher
High
Report
Form 4 Inhibikase Therapeutics, For: Jan 05 Filed by: Cabell Christopher
1/7
04:18 pm
ikt
Form 4 Inhibikase Therapeutics, For: Jan 05 Filed by: McIntyre David
High
Report
Form 4 Inhibikase Therapeutics, For: Jan 05 Filed by: McIntyre David
12/31
05:01 pm
ikt
Form SCHEDULE 13G Inhibikase Therapeutics, Filed by: Trails Edge Capital Partners, LP
Medium
Report
Form SCHEDULE 13G Inhibikase Therapeutics, Filed by: Trails Edge Capital Partners, LP
12/19
04:18 pm
ikt
Form 8-K Inhibikase Therapeutics, For: Dec 19
Medium
Report
Form 8-K Inhibikase Therapeutics, For: Dec 19
12/19
04:15 pm
ikt
Form 424B5 Inhibikase Therapeutics,
Medium
Report
Form 424B5 Inhibikase Therapeutics,